Received May 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPAB | HEP A + HEP B (TWINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 4 | 797F9 | IM / LA |
In 2024, patient had to follow the Twinrix accelerated schedule due to her travel needs. The accelerated schedule should be 3 doses at 0, 7, and 21-30 days, followed by a booster dose at 12 months. She had her vaccine on 2/28/2024 , 3/6/2024, 3/20/2024, and her next dose after that should be 12 months later in 2025 . However, she came to the pharmacy on 3/29/2024 and received another Twinrix dose. Patient did not complain about any side effects. When she visited pharmacy again for her last dose on 5/18/2025. We checked her previous record, and we found out she should not receive the dose on 3/29/2024.